Avalo Therapeutics Statistics
Total Valuation
AVTX has a market cap or net worth of $241.74 million. The enterprise value is $129.16 million.
Important Dates
The next estimated earnings date is Friday, November 7, 2025, before market open.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVTX has 13.15 million shares outstanding. The number of shares has increased by 1,182.48% in one year.
| Current Share Class | 13.15M |
| Shares Outstanding | 13.15M |
| Shares Change (YoY) | +1,182.48% |
| Shares Change (QoQ) | +2.99% |
| Owned by Insiders (%) | 4.82% |
| Owned by Institutions (%) | 34.33% |
| Float | 6.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 548.16 |
| Forward PS | n/a |
| PB Ratio | 1.90 |
| P/TBV Ratio | 2.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 292.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.44, with a Debt / Equity ratio of 0.01.
| Current Ratio | 12.44 |
| Quick Ratio | 12.23 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -90.25% and return on invested capital (ROIC) is -71.73%.
| Return on Equity (ROE) | -90.25% |
| Return on Assets (ROA) | -32.01% |
| Return on Invested Capital (ROIC) | -71.73% |
| Return on Capital Employed (ROCE) | -51.27% |
| Revenue Per Employee | $19,174 |
| Profits Per Employee | -$2.01M |
| Employee Count | 23 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTX has paid $124,000 in taxes.
| Income Tax | 124,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.29% in the last 52 weeks. The beta is 0.95, so AVTX's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +27.29% |
| 50-Day Moving Average | 12.44 |
| 200-Day Moving Average | 7.76 |
| Relative Strength Index (RSI) | 70.27 |
| Average Volume (20 Days) | 409,215 |
Short Selling Information
The latest short interest is 1.30 million, so 9.90% of the outstanding shares have been sold short.
| Short Interest | 1.30M |
| Short Previous Month | 1.24M |
| Short % of Shares Out | 9.90% |
| Short % of Float | 18.73% |
| Short Ratio (days to cover) | 2.80 |
Income Statement
In the last 12 months, AVTX had revenue of $441,000 and -$46.22 million in losses. Loss per share was -$6.01.
| Revenue | 441,000 |
| Gross Profit | -28.16M |
| Operating Income | -60.16M |
| Pretax Income | -46.09M |
| Net Income | -46.22M |
| EBITDA | -59.78M |
| EBIT | -60.16M |
| Loss Per Share | -$6.01 |
Full Income StatementBalance Sheet
The company has $113.26 million in cash and $679,000 in debt, giving a net cash position of $112.58 million or $8.56 per share.
| Cash & Cash Equivalents | 113.26M |
| Total Debt | 679,000 |
| Net Cash | 112.58M |
| Net Cash Per Share | $8.56 |
| Equity (Book Value) | 104.57M |
| Book Value Per Share | 9.65 |
| Working Capital | 105.93M |
Full Balance SheetCash Flow
| Operating Cash Flow | -47.42M |
| Capital Expenditures | n/a |
| Free Cash Flow | -47.42M |
| FCF Per Share | -$3.61 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -13,640.59% |
| Pretax Margin | -10,451.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,182.48% |
| Shareholder Yield | -1,182.48% |
| Earnings Yield | -19.12% |
| FCF Yield | -19.62% |
Analyst Forecast
The average price target for AVTX is $30.14, which is 63.98% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.14 |
| Price Target Difference | 63.98% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 85.64% |
| EPS Growth Forecast (5Y) | -31.30% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 29, 2023. It was a reverse split with a ratio of 1:240.
| Last Split Date | Dec 29, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:240 |
Scores
AVTX has an Altman Z-Score of -3.07 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.07 |
| Piotroski F-Score | 1 |
